Erectile Dysfunction a Potential Target for Exopharm’s Exosomes
14 February 2020 An Australian-developed regenerative therapy is exploring the possibility of a treatment for Erectile dysfunction (ED) through stimulating the regenerative and healing capacities of the body. Exopharm Limited (ASX: EX1) has been testing its exosomes –…
The 3-D printed healthcare revolution
12 February 2020 By Michelle Wheeler, freelance science journalist, for Particle Need brain surgery? We’ll get printing now. Imagine you need a complicated and risky operation to insert an implant into your brain. The implant has been custom…
New Australian technology to treat lung disease
12 February 2020 Australian Associated Press Diagnosing lung disease will now be faster and more accurate, thanks to new non-invasive technology developed at Monash University. The technology will enable doctors to check if treatments for respiratory illnesses are…
Taskforce To Help Shape Victoria’s Innovation Agenda
13 February 2020 Taskforce To Help Shape Victoria’s Innovation Agenda Minister for Jobs, Innovation and Trade The Andrews Labor Government is bolstering Victoria’s position as a leading destination for tech and innovation by bringing together startups, universities, businesses…
Australia’s biotech innovations heading offshore, prompting calls for greater funding to bring them to market
13 February 2020 From ABC News By business reporter Rachel Pupazzoni The demand on the health sector has never been more evident, as the world scrambles to come up with a treatment for coronavirus. More than 1,000 people have…
Government fails in bid to block Senate inquiry
11 February 2020 The enabling legislation for proposed changes to the R&D Tax Incentive ha officially been referred to a Senate inquiry. The government failed in a bid to block the inquiry. Labor combined with the Greens and…
Under-the-radar BRII program surfaces
11 February 2020 James Riley, Editorial Director The Industry department’s Business Research and Innovation Initiative has been on a slow burn since it was announced as part of the National Innovation and Science Agenda in December 2015. The Challenge-based…
Patients with challenging cancers to benefit from genomic sequencing
12 February 2020 More than 1000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.…
Work commences on a new global HQ
11 February 2020 World leading biotech company CSL has commenced construction of its global headquarters in Parkville, the nation’s premier biomedical precinct, which will further cement Melbourne’s position as a world class research destination The new purpose-built facility, which…
David McIntyre appointed as non-executive director
12 February 2020 Melbourne, Australia: The Board of Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce the appointment of Mr David McIntyre as an independent non-executive director, effective 1 March 2020. Mr McIntyre has more than 20 years…
Independent Plexaris and Cevaris testing shows positive and unique results
12 February 2020 Melbourne, Australia: BioMAP testing of Exopharm’s exosome platform has validated safety and mechanism of action (MOA) and found that they have different and distinct activities compared to 4,500 other drugs. This confirms this therapeutic approach…
ARDC funding outcomes: Monash receives current funding for future tech
5 February 2020 Monash University has secured $4.3m from the Australian Research Data Commons (ARDC) to lead four major data and cloud infrastructure science projects, which significantly advance the artificial intelligence (AI), data science and research technology capabilities…
